Lead Product(s) : Substance P
Therapeutic Area : Dermatology
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Substance P Challenge in Healthy Participants
Details : Substance P is a Peptide drug candidate, which is currently being evaluated in clinical studies for the treatment of Skin Diseases.
Product Name : Undisclosed
Product Type : Peptide, Unconjugated
Upfront Cash : Inapplicable
December 21, 2020
Lead Product(s) : Substance P
Therapeutic Area : Dermatology
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Substance P
Therapeutic Area : Endocrinology
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Neuropeptide Therapy of Recent Onset Type 1 Diabetes
Details : Substance P is a Peptide drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Diabetes Mellitus, Type 1.
Product Name : Undisclosed
Product Type : Peptide, Unconjugated
Upfront Cash : Inapplicable
July 01, 2016
Lead Product(s) : Substance P
Therapeutic Area : Endocrinology
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable